The increased demand for anti-viral coatings is driven by national efforts on COVID-19 response and the cost-benefit to the medical and healthcare industry improving considerably. Major investment by large companies and governments will create significant market opportunities. As well as a huge increase in industry demand, there has been an surge in academic application focused research.
Advanced materials that that display anti-viral action and analysed in this report include:
- Adaptive biomaterials.
- Antibacterial peptides (AMPs).
- Antibacterials liquid metals.
- Nanosilver (NanoAg).
- NanoGold (NanoAu).
- Nanoparticle titanium dioxide (Nano-TiO2).
- Nano Copper(II) chloride (NanoCuCl2).
- Nano Cerium Oxide (NanoCeO2)
- NanoSilica (Nano-SiO2).
- Graphene oxide.
- Nano Zinc Oxide (NanoZnO).
- Carbon nanotubes.
- Chitosan nanoparticles.
- Nanocellulose (cellulose nanofibers and cellulose nanocrystals).
Markets impacted by Anti-Viral Coatings and analysed in this report include:
- Household and indoor surfaces.
- Surfaces for indoor poullutants and improving air quality (Photocatalytic oxidizers, filters and HVAC coatings).
- Medical and healthcare settings (medical surfaces, wound dressings, medical equipment and instruments, fabric supplies scrubs, linens, masks, implants).
The global injectables market is estimated to reach US$836.6 billion in 2026, progressing at a CAGR of 10.95%, over the period 2022-2026. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
U.S. Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CNS Diseases, Others), By End Use (Patients, Providers, Payers, Employers, Others), And Segment Forecasts, 2022 - 2030 U.S. Digital Therapeutics Market Growth & Trends The U.S. digital therapeutics...
Resistant Pseudomonas aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections – Drugs In Development, 2022, provides an overview...
Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 18.104.22.168) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Nicotinamide Phosphoribosyl...
Pyelonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pyelonephritis - Drugs In Development, 2022, provides an overview of the Pyelonephritis (Infectious Disease) pipeline...
The Global Human Microbiome Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 32.2% CAGR during the forecast period. The human microbiome is made up of all microbes found on or in human tissues and biofluids, as well as the anatomical places where they live, such as the skin, seminal fluid, mammary...
The Global Wearable Injectors Market size is expected to reach $12.9 billion by 2028, rising at a market growth of 9.2% CAGR during the forecast period. Wearable injectors (WIs) are drug delivery systems that anchor to the body and release significant amounts of medicine subcutaneously over time. Wearable injectors provide medications...
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Drugs In Development, 2022, provides an overview of the Genital Herpes (Infectious Disease) pipeline...
The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development &...
The global empty capsules market reached a value of US$ 2.61 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 4.14 Billion by 2027 exhibiting a CAGR of 7.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.